In a €2.75 million cash transaction, MedReleaf (TSX:LEAF) has acquired MED Colombia, a company with cannabis cultivation and production licenses in Colombia, the company announced on Wednesday (July 25).

Through the acquisition, MedReleaf can now produce low-cost, high-quality raw materials to serve its global supply chain, along with Colombia’s domestic medical cannabis market. MED Colombia’s license repertoire includes the production of cannabis oil extracts and a library of cannabis genetics.


“As the legalization of medical cannabis continues to expand, we must ensure that our ability to cultivate cost effectively extends beyond Canada to supply our global operations,” CEO of MedReleaf Neil Closner said in a statement.

“Colombia has one of the best climates in the world for cannabis cultivation and excellent regulation to protect the rights of growers and operators. With the acquisition of MED Colombia we continue to execute on our international strategy and will be well positioned to scale our global production as our business continues to grow.”

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Colombia legalized medical cannabis in 2015, while MED Colombia received its government license for THC cannabis cultivation, along with its derivatives, in 2017. MedReleaf has had a Colombian team operating in the country since 2017, and with this newest acquisition, can now accelerate plans to establish a licensed cultivation and extraction facility.

In April, MedReleaf announced that it had completed an acquisition agreement for 1 million square feet of existing greenhouse infrastructure on a 69 acre property in Exeter, Ontario, along with 95 acres of adjacent land, for $26 million. Set to be the company’s third Canadian facility, MedReleaf expects its first harvest in 2019’s first quarter.

As of market close on Wednesday, MedReleaf stocks were down 1.83 percent on the TSX to close at C$24.64. TipRanks analysis currently has a “Moderate Buy” ranking based off two analyst ratings  for the company’s shares with an average price target of C$34.

The most recent analyst ranking came in June, one from Noel Atkinson from Clarus, who reiterated his “Hold” position in the company, while Vivien Azer from Cowen & Co. reiterated her “Buy” position with a price target of C$34.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Olivia Da Silva, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The ongoing volatility seen in the cannabis investment market has left one of the most promising areas in the entire space in a bind.

Executives and investment experts across the market told the Investing News Network (INN) in recent conversations that the current style of cannabis investing can’t support the goals of publicly traded medical cannabis researchers and drug makers.

Keep reading... Show less

Le 18 octobreOctober 2021) Matica Enterprises Inc. (MMJ) has announced a name and symbol change to West Island Brands Inc. (WIB) and a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 10,712,484 common shares.

Keep reading... Show less

Florida’s capital city is where Trulieve opened its first retail location and will be home to its 100 th dispensary in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), the largest multi-state operator (MSO) in the United States today announced the opening of its 100 th dispensary in the state of Florida . The location is in Tallahassee, Florida where Trulieve opened its first store, and was formerly branded as Harvest House of Cannabis. Trulieve will host a ribbon cutting and begin serving patients at this location at 8:30 am on Tuesday, October 19 and will celebrate the milestone at all locations statewide.

Keep reading... Show less

Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the presentations from the KCSA Psychedelics Virtual Investor Conference are now available for on-demand viewing.

Keep reading... Show less

Matica Enterprises Inc. (CSE: MMJ) (FSE: 39N) (OTCQB: MMJFF) (“Matica” or the “Company”) is pleased to announce that the Company’s subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture (“West Island”) has signed a Master Supply Agreement with the Ontario Cannabis Retail Corporation, doing business as the Ontario Cannabis Store (the “OCS”), which is the sole wholesale distributor of cannabis for the province. West Island was selected as part of the OCS’s Limited Release program.

Matica CEO, Boris Ziger states, “We welcome the opportunity to introduce our OUESTTM brand of premium craft cannabis to Ontario. We begin our entry into Canada’s largest cannabis market with our flagship ‘Sweet Demon’, a super premium product that has become an instant classic in the Prairies. It is a privilege to be able to serve the people of Ontario and deliver the kind of rare quality that the market is now demanding.”

Keep reading... Show less